Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells

Overview of attention for article published in Frontiers in immunology, July 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 38,073 followers.

Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells #MECFS #LongCovid https://t.co/gdGTfUXTqk https://t.co/hYQ0SuOlT4

RT @FrontImmunol: New Research: Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells https://t.co/Ab9dJ5BB1R #…

RT @FrontImmunol: New Research: Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells https://t.co/Ab9dJ5BB1R #…

RT @FrontImmunol: New Research: Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells https://t.co/Ab9dJ5BB1R #…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.